ImmunityBio, Inc.

IBRX

—

Advanced chart & tools →

ImmunityBio, Inc.IBRX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.38

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$113.29M

Net income

$-351.40M

Net margin

-310.2%

Gross margin

—

Dividends & financials

ImmunityBio, Inc. (IBRX) reported revenue of $113.29M and net income of $-351.40M, or $-0.38 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.